ATP6V1G1P1

Across TCGA pan-cancer cohorts, ATP6V1G1P1 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated ATP6V1G1P1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher ATP6V1G1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ATP6V1G1P1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SARC show a favorable association.

STAD, THCA, and CESC are the cancer types where ATP6V1G1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.527	0.681	.002	36	view →
THCA	DFS	Tertile	II,III,IV	0.459	0.878	<.001	36	view →
CESC	DFS	Tertile	II,III,IV	0.173	0.705	.028	18	view →
HNSC	OS	Tertile	All	1.000	0.383	.024	18	view →
SKCM	OS	Tertile	II,III,IV	0.436	0.745	.010	9	view →
LUSC	OS	Tertile	II,III,IV	0.517	0.801	.015	9	view →
COAD	OS	Tertile	III,IV	0.246	0.699	.038	9	view →
SARC	DFS	Tertile	All	1.000	0.361	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

ATP6V1G1P1–STAD (DFS)

Open the STAD breakdown →